This might suggest that the lack of NTproBNP prognostic ability might be attributed to the limited cohort or the narrow NT-proBNP range investigated in the current study, as it was specifically designed to clarify the clinical significance of moderately elevated NT-proBNP, particularly in subjects without HF or relevant valvular heart disease. This evidence concerns the gene NPPB and hydrops fetalis.